NovaBridge Biosciences
NBP
$1.70
-$0.08-4.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -18.93M | -18.93M | -72.86M | -6.83M | -- |
| Total Depreciation and Amortization | 301.00K | 301.00K | 216.00K | 216.00K | -- |
| Total Amortization of Deferred Charges | 1.90M | 1.90M | -- | -- | -- |
| Total Other Non-Cash Items | 3.16M | 3.16M | 47.77M | 1.46M | -- |
| Change in Net Operating Assets | -2.89M | -2.89M | 10.28M | 6.99M | -- |
| Cash from Operations | -16.46M | -16.46M | -14.60M | 1.84M | -- |
| Capital Expenditure | -495.00K | -495.00K | 0.00 | 0.00 | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.62M | 6.62M | 0.00 | 0.00 | -- |
| Cash from Investing | 6.12M | 6.12M | 0.00 | 0.00 | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 371.00K | 371.00K | 200.00K | 61.71M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -3.22M | -966.00K | -- |
| Cash from Financing | 371.00K | 371.00K | -3.02M | 60.75M | -- |
| Foreign Exchange rate Adjustments | -27.00K | -27.00K | 187.00K | 73.00K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -10.00M | -10.00M | -17.43M | 62.66M | -- |